• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

Introduction to 2-(Trifluoromethoxy)ethylaminobenzene (CAS No. 175278-25-8)

2-(Trifluoromethoxy)ethylaminobenzene, with the CAS number 175278-25-8, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a trifluoromethoxy group and an aminoethyl side chain attached to a benzene ring. These structural features contribute to its potential applications in various biological and medicinal contexts.

The chemical structure of 2-(Trifluoromethoxy)ethylaminobenzene is represented by the formula C₉H₁₀F₃NO₂. The presence of the trifluoromethoxy group imparts unique electronic and steric properties, making it a valuable scaffold for the design and synthesis of novel bioactive molecules. The aminoethyl side chain, on the other hand, provides opportunities for further functionalization and optimization of the compound's biological activity.

In recent years, there has been a growing interest in the development of fluorinated compounds for pharmaceutical applications due to their enhanced metabolic stability and improved pharmacokinetic properties. 2-(Trifluoromethoxy)ethylaminobenzene is one such compound that has shown promise in this regard. Studies have demonstrated its potential as a lead compound for the development of new drugs targeting various diseases, including neurological disorders, cancer, and inflammatory conditions.

One of the key areas of research involving 2-(Trifluoromethoxy)ethylaminobenzene is its use as a scaffold for the synthesis of selective serotonin reuptake inhibitors (SSRIs). SSRIs are a class of antidepressants that work by increasing the levels of serotonin in the brain. The unique structure of 2-(Trifluoromethoxy)ethylaminobenzene allows for the design of derivatives with enhanced selectivity and potency, potentially leading to more effective and safer antidepressant medications.

Beyond its applications in neuropharmacology, 2-(Trifluoromethoxy)ethylaminobenzene has also been explored for its potential as an anticancer agent. Research has shown that certain derivatives of this compound exhibit significant cytotoxic activity against various cancer cell lines. The mechanism of action appears to involve the induction of apoptosis and inhibition of cell proliferation, making it a promising candidate for further development in oncology.

In addition to its therapeutic potential, 2-(Trifluoromethoxy)ethylaminobenzene has also been studied for its use as a probe in biochemical assays. Its unique electronic properties make it suitable for labeling and tracking biomolecules, which can provide valuable insights into cellular processes and disease mechanisms. This application has particular relevance in areas such as proteomics and metabolomics, where precise labeling agents are essential for accurate analysis.

The synthesis of 2-(Trifluoromethoxy)ethylaminobenzene typically involves multi-step processes that require careful control of reaction conditions to ensure high yields and purity. Common synthetic routes include nucleophilic substitution reactions and coupling reactions using appropriate protecting groups to prevent unwanted side reactions. Advances in synthetic chemistry have led to more efficient and scalable methods for producing this compound, facilitating its broader use in research and development.

To further enhance the utility of 2-(Trifluoromethoxy)ethylaminobenzene, researchers are actively exploring strategies to modify its structure and functional groups. For example, introducing additional fluorine atoms or substituting other functional groups can alter the compound's pharmacological properties, leading to new derivatives with improved efficacy or reduced side effects. Computational methods, such as molecular docking and quantum mechanics calculations, are often employed to predict the behavior of these modified compounds before they are synthesized and tested experimentally.

In conclusion, 2-(Trifluoromethoxy)ethylaminobenzene (CAS No. 175278-25-8) is a multifaceted compound with significant potential in various areas of medicinal chemistry and pharmaceutical research. Its unique structural features make it an attractive scaffold for the development of new drugs targeting neurological disorders, cancer, and other diseases. Ongoing research continues to uncover new applications and optimize its properties, highlighting its importance in advancing therapeutic options and scientific understanding.

• 329710-80-7(N-[2-(trifluoromethoxy)ethyl]aniline)
• 886049-93-0(1,2-Benzenediamine, 4-bromo-N1-[2-(trifluoromethoxy)ethyl]-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)